BIO-NIVESH Platform

-NIVESH Platform

Context

The Union Minister of State (Independent Charge) for Science & Technology recently launched the BIO-NIVESH Platform to boost private investment in biotechnology innovations.

Key Features

  1. It is a platform that links biotechnology and deep-tech startups with investors, especially for technologies approaching scale-up and commercialisation.
  2. Organized by: It has been organized by BIRAC (Biotechnology Industry Research Assistance Council) under the Department of Biotechnology (DBT).
  3. Ministry Involved: It comes under the Ministry of Science & Technology.
  4. Selection Criteria: Focuses on innovation, market potential, scalability, development stage and regulatory readiness.
  5. Two-way Engagement: Helps startups understand investor needs and investors assess scientific and regulatory requirements.
  6. Recurring Initiative: Future editions will be held in different cities to strengthen regional biotech ecosystems.
  7. Inaugural Edition: Included 20 startups and around 50 investors.
  8. Focus Areas: Capital access, commercialisation and scale-up of biotechnology innovations.

 

Significance for Biotechnology Ecosystem

  1. Bridges the funding gap between research and commercialisation.
  1. Promotes the transition of innovations from research → entrepreneurship → industry → market.
  1. Strengthens India’s biotechnology and deep-tech ecosystem through greater private investment.

 FAQs

Q1. What is the BIO-NIVESH Platform?
Ans: It is a platform that connects biotechnology startups with investors to facilitate private investment in innovations ready for scale-up and commercialisation.

Q2. What is the main objective of BIO-NIVESH?
Ans: Its key objective is to improve access to private capital for promising biotechnology innovations and help convert research into commercially viable products.

Q3. How is BIO-NIVESH different from a conventional investor-startup meeting?
Ans: It is designed as a two-way engagement platform, combining investor interaction with discussions on the scientific, regulatory and commercial challenges specific to biotechnology.